CO-DIAGNOSTICS INC's ticker is CODX and the CUSIP is 189763105. A total of 74 filers reported holding CO-DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,289 | +22.8% | 2,160 | +28.6% | 0.00% | – |
Q2 2023 | $1,864 | -72.8% | 1,680 | -63.7% | 0.00% | – |
Q1 2023 | $6,852 | -59.7% | 4,630 | -31.3% | 0.00% | – |
Q4 2022 | $17,000 | -29.2% | 6,744 | -7.5% | 0.00% | – |
Q3 2022 | $24,000 | -48.9% | 7,294 | -11.3% | 0.00% | – |
Q2 2022 | $47,000 | -13.0% | 8,226 | 0.0% | 0.00% | – |
Q1 2022 | $54,000 | -80.6% | 8,226 | -73.6% | 0.00% | -100.0% |
Q4 2021 | $278,000 | +124.2% | 31,199 | +142.9% | 0.00% | – |
Q3 2021 | $124,000 | -3.9% | 12,846 | -17.1% | 0.00% | – |
Q2 2021 | $129,000 | -15.1% | 15,495 | -2.6% | 0.00% | – |
Q1 2021 | $152,000 | -31.5% | 15,909 | -33.3% | 0.00% | -100.0% |
Q4 2020 | $222,000 | -77.8% | 23,846 | -67.5% | 0.00% | -66.7% |
Q3 2020 | $1,002,000 | +116.4% | 73,316 | +206.1% | 0.00% | +50.0% |
Q2 2020 | $463,000 | +328.7% | 23,955 | +73.4% | 0.00% | – |
Q1 2020 | $108,000 | – | 13,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Advisor Resource Council | 263,358 | $1,628,000 | 0.49% |
SummerHaven Investment Management, LLC | 114,800 | $709,000 | 0.40% |
Prairiewood Capital, LLC | 59,145 | $366,000 | 0.26% |
Aristides Capital LLC | 60,000 | $371,000 | 0.23% |
EASTERLY INVESTMENT PARTNERS LLC | 142,190 | $879,000 | 0.07% |
AXS Investments LLC | 24,980 | $154,000 | 0.06% |
Physician Wealth Advisors, Inc. | 40,375 | $188,000 | 0.05% |
HUSSMAN STRATEGIC ADVISORS, INC. | 36,000 | $222,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,800 | $1,742,000 | 0.03% |
SUMMIT WEALTH & RETIREMENT PLANNING, INC. | 14,248 | $88,000 | 0.03% |